Friday, September 22, 2017
FDA is updating its existing warnings on the dangers of combining addiction medications and certain anxiety and insomnia drugs to emphasize that despite the potential for potentially deadly interactions, medication-assisted treatment (MAT) for...
Tuesday, September 19, 2017
Significantly fewer African-Americans, Hispanics, Asians and non-Hispanic whites say ‘lack of trust’ is a reason why individuals do not participate in clinical trials, indicating a more favorable perception of this research. In a recent public...
Tuesday, September 19, 2017
​When I started my career as a physician more than 30 years ago, I could only dream of the breakthroughs I’d come to witness.
Tuesday, September 12, 2017
Drug overdose deaths escalated in 2016, as the nation has struggled with one of the worse public health crises in U.S. history – the opioid epidemic.
Friday, September 8, 2017
The Food and Drug Administration is undertaking a wide-ranging review of its existing regulations and inviting the public to comment on policies that are duplicative, out of date or overly burdensome. The FDA published seven federal register notices...
Friday, September 8, 2017
The search to prevent, contain, and eradicate global pandemics and other life-threatening conditions is underway in laboratories across the United States and around the world, thanks in large part to training provided by the Fogarty International...
Friday, September 8, 2017
FDA plans to unveil a new Strategic Policy Roadmap outlining the agency's policy priorities, one of which will be rolling out new pre-clinical science policies aimed at streamlining the investigational new drug and biologics license application...
Friday, September 8, 2017
With the coming influx of new types of medical technology like the recently approved gene therapy cancer treatment CAR-T, FDA needs to shift the way it evaluates safety and effectiveness, Commissioner Scott Gottlieb said in a speech Thursday . Many...
Thursday, September 7, 2017
The FDA's oversight of new drugs and devices would shift the emphasis from the investigational stage to the patient care setting under a plan to overhaul the agency's regulations. Scott Gottlieb, commissioner of the Food and Drug Administration,...
Thursday, September 7, 2017
Food and Drug Administration commissioner Scott Gottlieb said the FDA is hurrying to modernize the way it evaluates a flood of new drug applications derived from the fast-growing fields of gene and cell therapy. In a talk Thursday before a coalition...


Media Contacts

Suzanne Ffolkes
VP Communications

Anna Briseño
Senior Manager of Communications

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America